Vaccines and methods for controlling adiposity
US-9675679-B2 · Jun 13, 2017 · US
Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
US8980249B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980249-B2 |
| Application number | US-201113701498-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 3, 2011 |
| Priority date | Jun 3, 2010 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Agonists of growth hormone releasing hormone promote islet graft growth and proliferation in patients. Methods of treating patients comprise the use of these agonists.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating a patient diagnosed with diabetes comprising: exposing islet cells in vitro to an agent selected from growth hormone releasing hormone (GHRH) and an agonist of growth hormone releasing hormone (GHRH); washing the islet cells after the exposure step to remove the agent; transplanting the exposed islet cells into a patient; and administering a therapeutically effective amount to the patient an agent selected from growth hormone…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8980249B2 cover?
- Agonists of growth hormone releasing hormone promote islet graft growth and proliferation in patients. Methods of treating patients comprise the use of these agonists.
- Who is the assignee on this patent?
- Schally Andrew Victor, Ludwig Barbara, Bornstein Stefan, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C07K14/60. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).